A novel camptothecin-derivative anti-tumor agent. CKD-602-related toxicities induced by IV infusion administration have not yet been evaluated, although the drug is more widely used in clinical settin
相关文献及参考
Hertzberg, R., et al.: J. Med. Chem., 32, 715 (1989),
Hashimoto, H., et al.: Clin. Cancer Res., 1, 369 (19950, Dahut, W., et al.: J. Clin. Oncol., 14, 1236 (1996),